SV

Suresh Vilakathala Velayudhannair

Active Director Designated Partner DIN 11666935
DIN 11666935 First appointment Apr 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Vilakathala Velayudhannair

Data last updated:

Suresh Vilakathala Velayudhannair is a Designated Partner at Future To Medicine Consultancy Llp (since 2026).

DIN 11666935
Primary Designation Designated Partner
First Appointment 17 Apr 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Apr 20262026Active

Board colleagues of Suresh Vilakathala Velayudhannair

NameDINCompanyDesignation
Anil Moorayil Aniyan11666936Future To Medicine Consultancy LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Future To Medicine Consultancy Llp
Premium access

Shareholding and investment profile for Suresh Vilakathala Velayudhannair

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Vilakathala Velayudhannair

Suresh Vilakathala Velayudhannair currently holds 1 directorship: Future To Medicine Consultancy Llp (Designated Partner, since 17 Apr 2026).

Suresh Vilakathala Velayudhannair was first appointed on 17 Apr 2026 as Designated Partner at Future To Medicine Consultancy Llp.

The current boards of Suresh Vilakathala Velayudhannair's companies include Anil Moorayil Aniyan (Future To Medicine Consultancy Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available